Our info demonstrate that CK18 is constantly expressed in numerous epithelial cancers, Specifically adenocarcinomas. the two loss of CK18 expression in cancers derived from CK18 positive precursor cells and neo-expression in malignancies derived from CK18 positive precursors are typically linked to unfavorable tumor phenotype and sickness outcome.